Accelerated Vaccine Trials during the COVID-19 Pandemic: A Methodological Review

Saba Siddiqui, Ravi M D, Shalini N and Joseph Richards

International Journal of Scientific Research in Science and Technology, 2025, vol. 12, issue 3, 1065-1072

Abstract: The COVID-19 pandemic catalyzed a paradigm shift in vaccine development, prompting the adoption of innovative clinical trial methodologies to accelerate timelines without compromising scientific integrity. This review critically examines the methodological adaptations employed during the development of COVID-19 vaccines, including overlapping and adaptive trial designs, the use of platform trials, regulatory flexibilities such as Emergency Use Authorizations, and the integration of decentralized and digitally enabled trial models. Ethical considerations, recruitment strategies, and challenges related to equity and public trust are also explored. While these innovations improved efficiency, they also highlighted the need for sustained attention to equity, transparency, and long-term safety monitoring in future vaccine research.

Keywords: Vaccine Trial; Clinical Trial Methodology; Adaptive Trial; Covid-19 (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ijsrst.com/home/article/view/IJSRST25123117 Abstract page (text/html)
https://ijsrst.com/home/article/download/IJSRST25123117/IJSRST25123117 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:etm:ijsrst:v12:y2025:i3:id:923

DOI: 10.32628/IJSRST25123117

Access Statistics for this article

More articles in International Journal of Scientific Research in Science and Technology from Technoscience Academy
Bibliographic data for series maintained by Pankaj Sharma ().